OptimizeRx (OPRX) Change in Accured Expenses (2010 - 2026)

OptimizeRx has disclosed Change in Accured Expenses across 17 years of filings, most recently posting $1.8 million for Q2 2026.

• In Q2 2026, Change in Accured Expenses fell 45.22% year-over-year to $1.8 million; the TTM figure through Jun 2026 stood at -$7.0 million (down 193.28% YoY), while the FY2025 annual figure was $3.4 million, up 220.42% from the prior year.
• Change in Accured Expenses came in at $1.8 million for Q2 2026 at OptimizeRx, up from -$8.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $3.3 million in Q2 2025 to a low of -$8.0 million in Q1 2026.
• Average Change in Accured Expenses over 5 years is -$42298.1, with a median of $146641.0 recorded in 2022.
• Year-over-year, Change in Accured Expenses soared 6010.65% in 2023 and sank 1035.48% in 2026.
• Over 5 years, Change in Accured Expenses stood at $936323.0 in 2022, then retreated by 15.2% to $794000.0 in 2023, then soared by 284.13% to $3.0 million in 2024, then sank by 52.1% to $1.5 million in 2025, then advanced by 23.13% to $1.8 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $1.8 million in Q2 2026, -$8.0 million in Q1 2026, and $1.5 million in Q4 2025.